THRIVENT LARGE CAP GROWTH PORTFOLIO

Thrivent Series Fund, Inc.

Actively managed U.S. equity fund
$3.23B NAV
45 positions · as of 2026-06-30 · filed 2026-08-26

Fund classification

Classified from what the fund holds · as of 2026 Q2

THRIVENT LARGE CAP GROWTH PORTFOLIO is an actively managed U.S. equity fund. 29% of THRIVENT LARGE CAP GROWTH PORTFOLIO’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 98% of the fund’s equity).

Asset class
Equity
Region
United States
Management
Actively managed
Fund type
Open-end fund
Features
Non-diversified

Fund profile

As filed in the prospectus · 2026 Q2

The investment objective of Thrivent Large Cap Growth Portfolio (the "Portfolio") is to achieve long-term growth of capital.

Strategy · summarised

The fund invests at least 80% of assets in equity securities of large-cap companies, defined as those with market capitalizations at or above the smallest company in the Russell 1000 Index or S&P 500 Index at the time of purchase. The adviser uses fundamental analysis to identify stocks expected to deliver above-average earnings growth or rapid sales and earnings expansion relative to the broader economy and market, with a tendency toward higher technology sector concentration. As a non-diversified fund, it may concentrate holdings in a relatively few number of issuers, creating risk that performance depends heavily on the success of those concentrated positions.

Expenses
0.43%one share class
Share classExpense ratio
C0000038310.43%

Portfolio turnover 40.00% · as of 2026 Q2

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

100.35%
of net assets
Stocks98.21%
Cash & short-term2.14%

Sector allocation

The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2

100%
of net assets
Information Technology40.8%
Communication Services14.7%
Consumer Discretionary12.6%
Industrials11.3%
7 smaller20.5%

Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).

Portfolio growth profile

How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2

Revenue growth
29%of stock holdings in top-quartile growers
covering 98% of the fund’s equity
Earnings growth
37%of stock holdings in top-quartile growers
covering 91% of the fund’s equity

Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 6 new3 exited

New: MU, GEV, CDNS, APH, SPCX, Thrivent Mutual Funds

Exited: SHOP, INTU, ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

1-year
+30.20%
3-year
+95.66%
5-year
+70.61%
Volatility
18.80%
Worst 3-yr fall
-12.25%
Cumulative return· Jul 2023 – Apr 2026

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
NVIDIA CORPORATIONNVDA10.85%$350.43M
AMAZON.COM INCAMZN7.45%$240.69M
APPLE INCAAPL6.14%$198.32M
ALPHABET INCGOOGL5.31%$171.37M
MICROSOFT CORPORATIONMSFT5.01%$161.85M
ALPHABET INCGOOG4.40%$141.95M
BROADCOM INCAVGO4.29%$138.69M
META PLATFORMS INCMETA3.62%$116.86M
LAM RESEARCH CORPORATIONLRCX3.43%$110.71M
ADVANCED MICRO DEVICES INCAMD2.96%$95.67M
Showing 10 of 45Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

Top 10 positions are 53.47% of net assets, top 25 82.92%, across 44 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free